🇬🇧 Hikma Pharmaceuticals PLC
Forum topic · HIK.L · Company page: financials, ownership and filings
Join the discussion on Hikma Pharmaceuticals PLC
Loading…
Product recall: Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 US
Drugs (FDA) published a recall by Hikma Pharmaceuticals USA INC. on 6 October 2026: Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12..
Reason: Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
Units affected: 2,136.
Mutual funds: 115 funds hold $483 million
115 mutual funds in 2 countries hold shares of Hikma Pharmaceuticals PLC worth $483 million, about 10.6% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 61 funds added shares and 65 sold; on balance they sold $75 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.